Narjust Duma on How Gender Affects the Tolerability of Immunotherapy

In this interview, we discuss a study of sex differences in the tolerability of anti –programmed death 1 immunotherapy among patients with metastatic melanoma.

Source: CancerNetwork - July 18, 2018 Category: Cancer & Oncology Authors: Narjust Duma, MD Source Type: news